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Abstract
Background: Asymptomatic subjects at intermediate coronary risk may need diagnostic testing for risk stratification.
Both measurement of coronary calcium scores and exercise testing are well established tests for this purpose. However,
it is not clear which test should be preferred as initial diagnostic test. We evaluated the prevalence of documented
coronary artery disease (CAD) according to calcium scores and exercise test results.
Methods: Asymptomatic subjects with ST-T changes on a rest ECG were selected from the population based PREVEND
cohort study and underwent measurement of calcium scores by electron beam tomography and exercise testing. With
calcium scores ≥10 or a positive exercise test, myocardial perfusion imaging (MPS) or coronary angiography (CAG) was
recommended. The primary endpoint was documented obstructive CAD (≥50% stenosis).
Results: Of 153 subjects included, 149 subjects completed the study protocol. Calcium scores ≥400, 100–399, 10–99
and <10 were found in 16, 29, 18 and 86 subjects and the primary endpoint was present in 11 (69%), 12 (41%), 0 (0%)
and 1 (1%) subjects, respectively. A positive, nondiagnostic and negative exercise test was present in 33, 27 and 89
subjects and the primary endpoint was present in 13 (39%), 5 (19%) and 6 (7%) subjects, respectively. Receiver operator
characteristics analysis showed that the area under the curve, as measure of diagnostic yield, of 0.91 (95% CI 0.84–0.97)
for calcium scores was superior to 0.74 (95% CI 0.64–0.83) for exercise testing (p = 0.004).
Conclusion: Measurement of coronary calcium scores is an appropriate initial non-invasive test in asymptomatic
subjects at increased coronary risk.
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In selected asymptomatic subjects with an intermediate
coronary risk profile, non-invasive testing may be
required for coronary risk stratification [1-5]. Guidelines
recommend the use of exercise testing [2,6,7] and meas-
urement of coronary calcium scores [8], since the predic-
tive values of both non-invasive tests for future coronary
events have been well established in asymptomatic sub-
jects at intermediate risk [7,9-11]. However, guidelines do
not recommend one of these tests as initial screening tool
in these subjects. Although an abnormal exercise test
result is widely accepted as indication for coronary angi-
ography (CAG)[12], the indications for an invasive diag-
nostic or therapeutic procedure have not yet been defined
for subjects with high calcium scores. This may be of par-
ticular importance for subjects with calcium scores ≥400,
since these subjects are at a high annual risk of cardiac
events of 4.8% [9]. So far, no head to head studies have
compared exercise testing with measurement of calcium
scores as initial tool in the evaluation of coronary artery
disease (CAD).
Our aim was to investigate the diagnostic yield of coro-
nary calcium scores and exercise testing in asymptomatic
subjects with an intermediate coronary risk profile. There-
fore, in a population based cohort study, all 12-lead rest
ECGs with ST depression (defined as Minnesota codes
4.1-2 (>0.5 mm ST-junctional depression)), T-wave inver-
sion (codes 5.1-2 (T wave inversion ≥1.0 mm)) or with an
abnormal frontal T-axis (-180° to -15° and 105° to 180°)
[13-17] were selected, after exclusion of the ECGs with
non-interpretable ST segments during the exercise test by
a clinical cardiologist [7]. These subjects are representative
for a study population at intermediate coronary risk, due
to the selection from a low risk population and in the
presence of ≥1 high risk characteristic [13-18]. First, we
investigated the prevalence of documented CAD. Second,
we investigated the invasive therapeutic implications
according to coronary calcium scores and exercise test
results.
Methods
Subjects
Asymptomatic male and female subjects with ST-T
changes on a 12-lead resting ECG were selected from the
prospective population based Prevention of REnal and
Vascular ENdstage Disease (PREVEND) cohort study in
Groningen, the Netherlands. The primary aim of this
cohort study is to assess the value of urinary albumin
excretion in relation to cardiovascular and renal risk. In
addition to the ECG, collected data include medical his-
tory, demographics, biometric data, urine- and blood col-
lections and laboratory measurements. The first visit has
taken place between 1997–1998. Subjects for the current
study were selected after the second visit (2001–2003).
Exclusion criteria were previous manifestations of coro-
nary heart disease (myocardial infarction, revasculariza-
tion procedure, or Q waves on the ECG) or coronary
angiography (CAG); age >70 years; and subjects in whom
the ST-T segment was not interpretable during the exercise
test due to atrial fibrillation or left bundle branch block
(LBBB) or ST depression >1 mm at 80 msec after the J
point [7]. For details on the PREVEND study design we
refer to earlier publications [19]. All participants under-
went measurement of calcium scores by EBT and exercise
testing. This PREVEND substudy was approved by the
medical ethics committee and conducted in accordance
with the guidelines of the declaration of Helsinki. All par-
ticipants have given written informed consent.
Electrocardiography
Standard 12-lead ECGs were recorded with Cardio Perfect
equipment (Cardio Control, Delft, The Netherlands),
stored digitally, and classified according to the Minnesota
code, using the computer program MEANS (Modular ECG
Analysis System) [20]. Signal analysis and classification of
MEANS have been extensively evaluated [21,22]. ST-T seg-
ment changes were defined by Minnesota codes 4.1-2 (ST-
junctional depression = 0.5 mm) and 5.1-2 (negative T-
wave ≥1 mm) or abnormal mean frontal T-axis (-180° to
-15° and 105° to 180°) [13-18]. T axes were computed
from vectorcardiographic X, Y and Z leads, which can, in
good approximation, be reconstructed from the standard
ECG leads [23]. The mean spatial axis was obtained by
vectorially adding the instantaneous heart vectors during
the T wave. The mean frontal T axis is the angle between
the X axis and the projection of the mean spatial T axis on
the frontal XY plane. Q waves were defined by Minnesota
codes 1.1–1.3 [17]. All ECGs were reviewed by a senior
clinical cardiologist in order to exclude the ECGs of which
the ST-T segment was not interpretable during the exercise
test.
Measurement of coronary calcium scores
Coronary calcium was measured using electron beam
tomography (EBT) (e-Speed, GE Medical Systems, South
San Francisco, USA). According to subjects' weight and
size the beam speed was set to 50 ms (for small or slender
patients) or 100 ms (for larger patients). Prospective ECG
triggering was used and set at 42% of the R-R interval.
Scans were made without the use of a contrast agent with
130 kV and 895 mAs. A single collimation of 3.0 mm and
an increment of 3.0 mm was applied. Total radiation
exposure was <1 mSv for each patient. The coronary cal-
cium score was obtained by multiplying each area of inter-
est with a factor indicating peak density within the
individual area, as was proposed by Agatston [24].Page 2 of 9
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As is common practice in the Netherlands, all exercise
tests were performed on a bicycle. Exercise tests were per-
formed in accordance with the guidelines for exercise test-
ing [6,7]. All exercise tests were independently reviewed
by a cardiologist (RT) and a research physician (CG), who
reached consensus in all cases. Exercise test end points
were defined as follows: positive, in case of ECG evidence
of myocardial ischemia (≥1.0 mm horizontal shift of the
ST segment at 80 msec after the J point compared to the
baseline ECG) and/or in case of 30 mmHg decrease in
systolic blood pressure and/or ventricular arrhythmia
and/or typical angina; intermediate, in case of <1.0 mm
ST depression as compared to baseline and/or aspecific
anginal complaints in the absence of ECG evidence of
ischemia; negative, in the absence of any of the above
mentioned criteria; and non-interpretable, if <85% of the
age- and sex- predicted heart rate or a rate pressure prod-
uct <18,000 was achieved. Intermediate and non-inter-
pretable results are considered as "nondiagnostic test
results".
Protocol
All patients underwent measurement of coronary calcium
scores by EBT and exercise testing. Test performance was
evaluated according to the decision protocol as given in
figure 1. In case of calcium scores ≥10, or positive exercise
test result, CAG or MPS was recommended to evaluate the
presence of obstructive CAD (figure 1). In subjects with
calcium scores <10 and a negative or nondiagnostic exer-
cise test result, a test to document obstructive CAD was
not recommended. In this population the presence of
obstructive CAD is almost fully excluded due to the high
negative predictive value of low calcium scores on CAD
[9,10,25]. In subjects with calcium scores <10 and a posi-
tive exercise test and in subjects with calcium scores 10–
99, the first choice recommended test was myocardial per-
fusion scintigraphy (MPS), followed by CAG in case of
abnormal results. In subjects with calcium scores 100–
399 and in subjects with calcium scores ≥400, the first
choice recommended test was CAG.
Endpoints
The primary endpoint was defined as documented CAD,
i.e. presence of obstructive significant CAD (≥50% lumi-
nal obstruction), based on CAG, or MPS, in case CAG was
not available. Myocardial perfusion scintigraphy was per-
formed as previously described [26]. All CAGs were re-
analysed by a senior cardiologist (FZ), without knowledge
of the clinical data. By qualitative analysis the coronary
arteries were graded as follows: normal coronary arteries,
defined as the absence of any coronary lesion; non-
obstructive CAD, if maximal luminal obstructions were
<50%; and obstructive CAD, if lesions obstructed the
lumen ≥50% (i.e. documented CAD). The secondary end-
point was a class I or IIa indication for a revascularization
procedure (percutaneous coronary intervention (PCI) or
coronary artery bypass graft surgery (CABG)) according to
the ESC and ACC/AHA guidelines for PCI and CABG [27-
29]. Decisions to perform a revascularization procedure
were taken by the Thoraxcenter multidisciplinary heart
team. In case of obstructive CAD (= 50% luminal steno-
sis), either MPS, or fractional flow reserve (FFR) measure-
ment [30,31] was performed to guide the decision for a
revascularization procedure. An FFR <0.75 was an indica-
tion for a revascularization procedure. All subjects were
followed for the occurrence of cardiac events, i.e. myocar-
dial infarction or coronary death. Cardiac events were col-
lected by review of the subject's medical record,
questionnaire or telephone interview.
Statistical analysis
Continuous data are expressed as mean ± standard devia-
tion. Hypertension was defined as a systolic blood pres-
sure >140 mmHg and/or diastolic >90 mmHg or use of
antihypertensive medication. Left ventricular hypertrophy
(LVH) on the ECG was defined according to the Cornell
voltage-duration product [19]. Framingham risk estima-
tions were calculated according to Wilson et al [32]. Since
HDL cholesterol was not measured during the second
visit, HDL cholesterol data of the first visit were used for
the Framingham risk estimations. Significance was
reached when p < 0.05. To compare the diagnostic yield of
calcium scores with exercise test results, receiver operating
characteristic (ROC) curve analysis was performed. We
compared the area under the curves of both tests for the
primary and the secondary endpoints. For the ROC anal-
ysis, subjects with calcium scores <10 and a negative or
nondiagnostic exercise test and in whom MPS or CAG was
not performed, were assumed to have no endpoints. Cal-
culations were performed using the statistical package
Decision protocol*Figure 1
Decision protocol*. *see text for explanation. Abbrevia-
tions: CAG, coronary angiography; MPS, myocardial per-
fusion scintigraphy.
Calcium score <10
Calcium score 10-99 + any exercise test result
Calcium score ≥100 + any exercise test result
EBCT + exercise test
Nondiagnostic exercise test
MPS ± CAG
CAG ± MPS
Follow up
(n=149)
(n=86)
(n=18)
Positive exercise test
Negative exercise test
(n=9)
(n=10)
(n=67)
(n=45)Page 3 of 9
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(College Station, Texas, USA).
Results
Baseline characteristics
In 6,804 (99%) of 6,894 subjects participating in PREV-
END between 2001–2003, a 12-lead resting ECGs was
recorded. Of 481 (7%) subjects with ST-T changes on the
ECG, 291 subjects had any of the following characteris-
tics, namely previous manifestation of coronary heart dis-
ease; age >70 years; atrial fibrillation; LBBB or ST
depression >1.0 mm at 80 msec after the J point. Of 190
subjects invited, 153 responded (81%) and were
included. Baseline characteristics of the participants are
shown in table 1. Of the 11 subjects with ECG criteria for
LVH, 5 had calcium scores of 0 and 6 between 16 and
1313. The 10-year estimated Framingham risk was <10%
in 49%, 10–20% in 22% and >20% in 29% of subjects.
Test results
Eighty-six (58%) participants had low calcium scores
(<10), 18 (12%) had calcium scores 10–99, 29 (19%) par-
ticipants had calcium scores 100–399 and 16 (11%) par-
ticipants had high calcium scores (= 400). Exercise test
characteristics are shown in table 2. Significant ST depres-
sion occurred in 19% of subjects and angina was present
in 2%. Eighty-nine (60%) participants had a negative
exercise test result, while 27 (18%) had a nondiagnostic
and 33 (22%) had a positive exercise test result.
Endpoints
Four patients refused to undergo CAG or MPS as recom-
mended by the decision protocol, namely one patient
with calcium scores <10 and a positive exercise test; one
patient with calcium scores 10–99 and a positive exercise
test; one patient with calcium scores 10–99 and a negative
exercise test; and one patient with calcium scores ≥400
and positive exercise test result. Therefore, outcome was
obtained in 149 participants (100%) during 14 ± 3
months of follow up. No cardiac events occurred during
follow up. The primary endpoint (documented CAD) was
present in 24 (16%) participants. In 16 (11%) partici-
pants, the secondary endpoint, a Class I or IIa indication
for revascularization procedure, was present according to
the ESC and ACC/AHA guidelines for PCI and CABG in
asymptomatic patients [27-29].
The diagnostic yield of coronary calcium scores compared 
to the exercise test
Results are shown in table 3 and figure 2. The primary and
secondary endpoints were present in, respectively, 69%
and 63% of 16 subjects with calcium scores = 400 and in,
respectively, 39% and 27% of 33 subjects with a positive
exercise test. In 37% of the 33 subjects with a positive
exercise test, the absence of CAD was confirmed by a low
calcium score and/or normal coronary arteries at CAG. A
false negative test result was observed in 1% of 86 subjects
with calcium scores <10 and in 7% of 89 subjects with a
Table 2: Exercise test characteristics*
Rest
Heart rate, per minute 75 (13)
Systolic blood pressure, mmHg 142 (23)
Diastolic blood pressure, mmHg 83 (11)
Exercise
Heart rate, per minute 147 (27)
Systolic blood pressure, mmHg 205 (32)
Diastolic blood pressure, mmHg 90 (16)
Exercise capacity, Watt 151 (57)
Rate pressure product 30,141 (7,381)
Significant ST depression, No. (%)† 29 (19)
>30 mmHg decrease in blood pressure, No. (%) 3 (21)
Ventricular arrhythmia, No. (%) 5 (3)
Angina, No. (%) 3 (2)
Recovery
Heart rate, per minute 97 (21)
Systolic blood pressure, mmHg 145 (37)
Diastolic blood pressure, mmHg 76 (19)
*Values are given in mean (SD) unless indicated.
†for definition please see methods section
Table 1: Baseline characteristics
Characteristics n = 153
Age, mean (SD), y 56 (9)
Male gender, No. (%) 88 (58)
Blood pressure, mean (SD), mm Hg
Systolic 133 (23)
Diastolic 76 (10)
Hypertension, No. (%) 75 (49)
Current smoking, No. (%) 30 (20)
Diabetes, No. (%) 15 (10)
History of Cerebrovascular accident, No. (%) 3 (2)
History of Peripheral Arterial Disease, No. (%) 2 (1)
History of Valvular Heart Disease, No. (%) 0 (0)
Total cholesterol, mean (SD), mmol/L 5.5 (1.1)
Albuminuria, median (interquartile range), mg/24 h 8.7 (5.9–17.3)
Medication, No. (%)
Lipidlowering 29 (19)
Antihypertensive medication 62 (41)
Diuretics 37 (24)
Betablockers 24 (16)
ACE/AII blockers 30 (20)
Calciumantagonists 8 (5)
Aspirin 13 (9)
Antidiabetic treatment 15 (10)
Left ventricular hypertrophy criteria, No. (%) 11 (7)
Abbreviations: HDL, high density lipoprotein
SI conversion factor: to convert mmol/L to mg/dL, divide values for 
total cholesterol and HDL cholesterol by 0.0259 and divide values for 
triglycerides by 0.0113.Page 4 of 9
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scores <10, a positive exercise test and obstructive CAD
was a non-diabetic, male 56-year old subject, a past
smoker, who underwent a revascularization procedure for
a left main stenosis. With regard to the primary endpoint,
ROC statistics show an increased diagnostic yield of cal-
cium scores above exercise testing: the area under the
curve is 0.91 (95% CI 0.84–0.97) for calcium scores ver-
sus 0.74 (95% CI 0.64–0.83) for exercise testing (p =
0.004; figure 3). With regard to the secondary endpoint,
ROC statistics show a similar pattern, albeit not statisti-
cally significant: the area under the curve is 0.90 (95% CI
0.78–1.00) for calcium scores versus 0.73 (95% CI 0.52–
0.93) for exercise testing (p = 0.170; figure 3).
Discussion
Principal findings
Our results show that the diagnostic yield of measurement
of coronary calcium scores for documented obstructive
CAD is clearly superior to exercise testing in asympto-
matic subjects at increased coronary risk. Furthermore,
compared to exercise testing, high calcium scores identi-
fied a higher number of subjects with a class I or IIa indi-
cation for a revascularization procedure according to the
ESC and ACC/AHA guidelines for PCI and CABG.
General comments
Non-invasive testing, such as measurement of coronary
calcium scores and exercise testing, have become well
established tests for risk stratification in selected asympto-
matic subjects encountered in clinical practice. [1,2,6-8]
Both tests provide fundamentally different diagnostic
information. Coronary calcifications are highly specific
for atherosclerosis and a strong correlation with total
plaque burden has been demonstrated [33,34]. Coronary
calcifications parallel the development of atherosclerosis,
with higher values present in men and in the elderly [35].
Higher amounts of coronary calcium have been associ-
ated with more severe CAD [33,34,36,37]. Coronary calci-
fications have been associated with hard as well as with
soft plaques [38]. In ultrasound studies the sensitivity for
the detection of soft plaques is lower than for hard
plaques [38]. However, since the absence of coronary cal-
cium has been associated with a negative predictive value
of >95% for future coronary events [39,40], (soft) plaques
maybe missed by EBCT have a limited clinical importance
[5]. Absolute coronary calcium scores, as well as age- sex-
specific percentiles, have been associated with the occur-
rence of future coronary events [35,39-41]. Measurement
of coronary calcium scores therefore focuses on the detec-
tion of CAD, while the exercise test focuses on the detec-
tion of myocardial ischemia. The "anatomic approach"
has the advantage that certainty on the absence of clini-
cally important CAD is obtained when calcium scores
equals zero. This is of clinical importance since many sub-
jects at intermediate risk (a probability of a coronary event
between 1–2% per year due to the presence of at least one
high risk characteristic or based on Framingham scores
[4,5]) do not have CAD [42-44].
In asymptomatic populations, guidelines traditionally
focus on long-term risk assessment and prevention of
future manifestations of coronary disease, while the role
of invasive diagnostic and therapeutic procedures is
hardly discussed [8,45]. Although high risk criteria on
stress testing in asymptomatic subjects are accepted as
indications for CAG [12], direct referral to CAG based on
high calcium scores is generally believed to be inappropri-
ate [12,46]. However, several arguments favor an invasive
strategy in subjects with high calcium scores. A clear asso-
Table 3: Endpoints
Calcium score Exercise test result No. (%) No. of CAG* No. of MPS* No. with primary endpoint† No. with secondary 
endpoint‡
<10 (n = 86) Positive 10/86 (12%) 3 7 1 1
Nondiagnostic 9/86 (10%) - - 0 0
Negative 67/86 (8%) - - 0 0
10–99 (n = 18) Positive 2/18 (11%) 1 1 0 0
Nondiagnostic 8/18 (44%) 4 4 0 0
Negative 8/18 (44%) 2 6 0 0
100–399 (n = 29) Positive 14/29 (48%) 11 3 6 2
Nondiagnostic 5/29 (17%) 3 2 2 1
Negative 10/29 (34%) 7 3 4 2
≥400 (n = 16) Positive 7/16 (44%) 7 0 6 6
Nondiagnostic 5/16 (31%) 3 2 3 2
Negative 4/16 (25%) 4 0 2 2
Abbreviations: CAG, coronary angiography; MPS, myocardial perfusion scintigraphy
*MPS was used for endpoint grading when CAG was not available
†primary endpoint, documented significant coronary artery disease
‡secondary endpoint, Class I or IIa indication for a revascularization procedure in asymptomatic patientsPage 5 of 9
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and the amount of myocardial ischemia [47-49] as well as
the severity of CAD [33,34,36], which are the principle
components of guideline recommendations for a revascu-
larization procedure [27-29]. In addition, event free sur-
vival was decreased in asymptomatic subjects with high
calcium scores and an abnormal myocardial perfusion
test [49]. Clearly, all subjects with high calcium scores
require aggressive secondary prevention, including treat-
ment with cholesterol lowering, antihypertensive medica-
tions and aspirin. Our research protocol recommended
performance of CAG in case of calcium scores = 400 or
positive exercise test result. The decision to perform a
revascularization procedure when a non-invasive stress
test had not been performed prior to CAG, was guided by
fractional flow reserve measurement during CAG
[12,30,31]. Alternative diagnostic strategies may be the
performance of CAG only after documentation of myocar-
dial ischemia by non-invasive stress testing [46], or in
combination with current generation CT-angiography.
We agree that an invasive strategy is associated with a risk
of complications and inappropriate revascularizations.
The recent COURAGE trial has shown that some patients
with stable CAD can be managed conservatively [50], and
future guidelines may therefore be adapted. Our multidis-
ciplinary study was based on the former ESC and ACC/
AHA guidelines for PCI and CABG [27-29], and identified
a substantial number of subjects with a class I or IIa indi-
cation for a revascularization procedure.
Twenty-nine subjects had a calcium score between 100–
399. When compared to subjects with calcium scores =
Receiver operator characteristic curvesFigure 3
Receiver operator characteristic curves. (a) primary 
endpoint (documented significant obstructive coronary 
artery disease) Area under the curve for coronary calcium 
scores 0.91 (95% CI 0.84–0.97); Area under the curve for 
exercise test 0.74 (95% CI 0.64–0.83). (b) secondary end-
point (Class I or IIa indication for revascularization proce-
dure) Area under the curve for coronary calcium scores 0.90 
(95% CI 0.78–1.00); Area under the curve for exercise test 
0.73 (95% CI 0.52–0.93)
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Endpoints according to coronary calcium scores and 
exercise test results. (a) primary endpoint (documented 
significant obstructive coronary artery disease) (b) secondary 
endpoint (Class I or IIa indication for revascularization proce-
dure). Abbreviations: neg., negative; nond., nondiagnostic; 
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or an indication for a revascularization procedure (17% vs
63%). This finding is in line with previous findings on the
increasing number of abnormal stress tests in case of
higher calcium scores, namely in 18–60% of subjects with
calcium scores = 400, compared to 7–23% of subjects
with calcium cores of 100–399 [47-49]. Since the finding
of myocardial ischemia in asymptomatic subjects with
calcium scores >100 affects clinical outcome [49], non-
invasive stress testing is warranted. This may be followed
by an invasive strategy in case of abnormal test results, in
addition to appropriate medical treatment. Further stud-
ies with larger numbers of patients are needed to evaluate
these issues.
Remarks and limitations
Thirthy-two patients (21.5%) used betablockers or cal-
cium antagonists at the time of exercise testing. These
medications may affect the maximal exercise heart rate
[51]. This may have contributed to a non-interpretable
result found in one case (0.7%). With regard to the exer-
cise test, information on the Duke score and ST-T hystere-
sis were not measured. Unfortunately, individual FFR
values were not registered. We used EBT to measure cal-
cium scores. Due to recent improvements in ECG gating
software, shorter scan times and higher resolutions, cur-
rent generation multi detector CT also provides accurate
calcium scores measurements with a radiation dose of 1.0
mSv [52]. Since multidetector CT scanners are more
widely available than EBT, our results, when extended to
multidetector CT scanners, may therefore influence clini-
cal practice. The sensitivity of the exercise test was some-
what lower than expected from large symptomatic
populations undergoing exercise testing and coronary
angiography [53]. However, the test characteristics of our
study were very comparable to the studies including only
asymptomatic subjects [7,54-56]. The specificity for high
calcium scores to detect significant CAD in our study pop-
ulation is similar to studies comparing calcium scoring
and CAG in symptomatic patients [36,37]. This observa-
tion implies that the association between calcium scores
and severity of CAD at CAG may be extendable to asymp-
tomatic populations. The current study population was
derived from the PREVEND population of subjects with-
out previous documented coronary heart disease, which
can be regarded as a low risk population since 3.3% expe-
rienced a first coronary event during 5.5 years of follow up
[57]. The presence of ST-T changes on the resting ECG is a
clear additional high risk characteristic, and therefore our
population can be classified as intermediate risk [13-18].
The prevalence of coronary calcium scores, in particular
with regard to the 30–50% of subjects having calcium
scores <10, was comparable to other asymptomatic popu-
lations with at least one risk factor [42,43]. Our results are
therefore applicable in asymptomatic populations, who
are candidates for risk stratification, based on the presence
of ≥1 high risk characteristic.
Conclusion
Measurement of coronary calcium scores is an appropriate
initial non-invasive test in asymptomatic subjects at
increased coronary risk. Furthermore, invasive diagnostic
and therapeutic procedures are indicated in a high
number of subjects with coronary calcium scores ≥400.
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